Drug compounders seeking to produce peptides are stepping into an unclear regulatory zone as the FDA reconsiders restrictions over the products that have gained popularity among wellness influencers.

A high-profile jury verdict against Live Nation Entertainment Inc. in a suit pursued by more than 30 states injects new momentum into private plaintiffs’ antitrust cases against the US concert promoter and further exposes the company to billions in damages.

The US Supreme Court sided with Chevron Corp. in a protracted fight over the proper venue for a lawsuit seeking to hold the oil and gas giant liable for the rapid erosion of Louisiana’s coastal wetlands.

A federal district court has given the EPA more time to release chemical documents so parties in two lawsuits can work to resolve Arkema Inc.'s concerns about the potential release of its confidential business information.

Seventeen years ago and change, Lehman Brothers collapsed, setting off a global financial crisis. For those of us who lived and blogged through it, the Great Recession (as it was known in the US) is seared into our memory, and no one wants to relive it. That’s why we’re so attuned to any Wall Street phenomena that might trigger another financial crisis: the AI bubble, perhaps, or the trillions of dollars in opaque credit instruments known as private credit.

US Health and Human Services Secretary Robert F. Kennedy Jr. acknowledged that vaccination may have saved the 6-year-old Texas child who died from measles last year, even as he defended the Trump administration’s controversial policies at a hearing on Capitol Hill Thursday.